Aveo Pharmaceuticals to pay U.S. SEC $4 mln to settle kidney drug case
March 29 (Reuters) - Biotech company Aveo Pharmaceuticals Inc will pay $4 million to settle civil charges that it misled investors about U.S. regulators' concerns involving its drug to treat kidney...
No comments:
Post a Comment